Doctor Profile

Dr. Abhishek Mahato

Consultant

MBBS, DNB (Nuclear Medicine), MNAMS, FANMB

  • YEARS OF PRACTICE: 21 Years
  • GENDER: Male
  • LANGUAGES SPOKEN: English, Hindi
Make an Appointment

Biography

Dedicated Nuclear Medicine Physician with a commitment to delivering compassionate, patient-centered care through the application of advanced technologies. Expertise in diagnosing and treating diseases using molecular imaging and therapies to enhance patient outcomes and quality of life. Proven collaborator with interdisciplinary healthcare teams, consistently seeking to remain current with the latest research and developments in the field. Upholds the highest standards of integrity, respect, and professionalism in all aspects of practice.

My Mantra

If you visualize a disease better, you treat it better.

PROCEDURES PERFORMED:

Oncological PET-CT; Myocardial viability; Dementia & movement disorders Imaging; Molecular Imaging in seizure disorder; Cardiac Amyloidosis and Sarcoidosis; Theranostics for benign & malignant thyroid disorders, Prostate and Neuro-endocrine tumours; Robotic PET-CT guided biopsies, Gamma camera based studies in nephrology, GI, pulmonology and cardiology.

TREATMENTS/PROCEDURES OFFERED:

  • Oncological PET-CT; Myocardial viability
  • Dementia & movement disorders Imaging
  • Molecular Imaging in seizure disorder
  • Cardiac Amyloidosis and Sarcoidosis
  • Theranostics for benign & malignant thyroid disorders
  • Prostate and Neuro-endocrine tumours
  • Gamma camera based studies in nephrology
  • GI
  • pulmonology and cardiology

NAME OF INSTITUTE(S):

    • MBBS - Armed Forces Medical College, Pune(June 2005 - March 2010)
    • DNB (Nuclear Medicine) - Army Hospital Research and Referral, New Delhi (March 2016 - June 2019)

FELLOWSHIPS:

    • Asian Nuclear Medicine Board (Seoul, South Korea).
    • Trained in Radiomolecular Precision Oncology (ICPO Academy of Theranostics, Germany)
  • Alavi-Takalkar-Kumar Award Received the second best paper award at SNMICON 2022 for the novel discovery of "Potential use of Empagliflozin in patients with controlling the deranged blood sugar before an 18F-FDG PET-CT - A Pilot study by Dr. Abbas Alavi, Dr. Amol Takalkar and Dr, Rakesh
  • Consultant Nuclear Medicine, Yashoda Hospital and Research Center Ltd., Nehru Nagar, Ghaziabad, U.P. (MAY 2024 --- JUNE 2026)
  • Asst Prof Nuclear Medicine, Command Hospital Central Command, Lucknow (JULY 2020 --- MARCH 2024)
  • Senior Resident, Army Hospital Research and Referral,, New Delhi (2019 --- JUNE 2020)
  • Discovered the novel use of SGLT2 inhibitors in FDG PET-CT.
  • Managed and expanded the efficiency of a high volume center successfully for 02 years.

PROFESSIONAL MEMBERSHIP:

  • Member of National Academy of Medical Sciences (MNAMS).
  • Society of Nuclear Medicine (SNMI)
  • Asian Nuclear Medicine Board (ANMB).
  • International Centers of Precision Oncology (ICPO).
  • Association of Nuclear Medicine Physicians of India (ANMPI).

Request An Appointment

This appointment request is for regular consultation with the Doctor at Kokilaben Hospital, Indore.

Patient Information

KDAH